Operating Lease, Right-of-Use Asset of Sagimet Biosciences Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sagimet Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • Sagimet Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $78,000, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sagimet Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $78,000 +$1,000 +1.3% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q3 2025 $115,000 +$1,000 +0.88% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $152,000 +$1,000 +0.66% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $38,000 +$1,000 +2.7% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $77,000 +$4,000 +5.5% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q3 2024 $114,000 +$5,000 +4.6% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $151,000 +$7,000 +4.9% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $37,000 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $73,000 -$139,000 -66% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 $109,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $144,000 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q4 2022 $212,000 31 Dec 2022 10-K 25 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.